IND Swift Laboratories

IND Swift Laboratories Goodwill

The Goodwill of IND Swift Laboratories (INDSWFTLAB.NS) as of Nov 20, 2026 is 351,000.00 INR. In the previous year, Goodwill was 2.11 M INR — a change of -83.39% (lower).

Goodwill

351,000.00INR

YoY

-83.39%

Last updated:

Goodwill of IND Swift Laboratories is 2022 351,000.00 INR. Goodwill of IND Swift Laboratories was 2021 2.11 M INR. It decreases by -83.39% lower compared to the previous year.

The IND Swift Laboratories Goodwill history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Goodwill
Date
Goodwill
Jan 1, 2015
2.12 M INR
Jan 1, 2016
2.12 M INR
Jan 1, 2017
2.12 M INR
Jan 1, 2018
2.12 M INR
Jan 1, 2019
2.11 M INR
Jan 1, 2020
2.11 M INR
Jan 1, 2021
2.11 M INR
Jan 1, 2022
351,000.00 INR
The IND Swift Laboratories Goodwill history
YEARGoodwillYoY
351,000.00INR-83.39%
2.11 MINR0.00%
2.11 MINR0.00%
2.11 MINR-0.24%
2.12 MINR0.00%
2.12 MINR0.00%
2.12 MINR0.00%
2.12 MINR-82.91%
12.39 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

IND Swift Laboratories Stock analysis

What does IND Swift Laboratories do? Ind-Swift Laboratories Ltd. generates revenue through the manufacturing and marketing of pharmaceutical ingredients, including Advanced Intermediates and reference standards for active pharmaceutical ingredients (APIs). The company supplies reference standards and impurities for over 25 APIs under pharmacopoeias such as British Pharmacopoeia (BP) and European Pharmacopoeia (EP), providing full documentation including Certificate of Analysis and MSDS with each shipment. Its research center, covering 40,000 square feet, develops process technology for APIs across various therapeutic categories, supporting both generic and innovative pharmaceutical organizations as API partners. The firm's primary customers are pharmaceutical companies requiring intermediates, formulations, and reference standards for API development and quality control. These organizations include both generic and innovative domain partners who rely on Ind-Swift's impurity portfolio and certified reference materials. The company's product offerings are tailored to meet the needs of clients in the pharmaceutical industry seeking compliant, high-quality raw materials and testing solutions. Ind-Swift's revenue streams are driven by the sale of Advanced Intermediates, reference standards, and impurities for APIs, with a focus on supplying documentation-compliant products. The company's API partnership model ensures consistent demand from clients needing reliable sources of pharmaceutical ingredients and testing materials, particularly for regulatory compliance in global markets. IND Swift Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IND Swift Laboratories stock

Goodwill of IND Swift Laboratories is 351,000.00 INR in 2022.

Goodwill of IND Swift Laboratories changed from 2.11 M INR to 351,000.00 INR, representing a -83.39% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Goodwill IND Swift Laboratories since 2006 – with annual values, charts, and detailed analysis.

Goodwill is the premium paid above fair market value in an acquisition. It represents intangible value such as brand recognition, customer relationships, and intellectual property.

Goodwill's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill's IND Swift Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — IND Swift Laboratories

All Key Metrics — IND Swift Laboratories